BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15557340)

  • 1. Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity.
    Yamamoto A; Friedlein A; Imai Y; Takahashi R; Kahle PJ; Haass C
    J Biol Chem; 2005 Feb; 280(5):3390-9. PubMed ID: 15557340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
    Im E; Chung KC
    J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.
    Hristova VA; Beasley SA; Rylett RJ; Shaw GS
    J Biol Chem; 2009 May; 284(22):14978-86. PubMed ID: 19339245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation.
    Yamano K; Queliconi BB; Koyano F; Saeki Y; Hirokawa T; Tanaka K; Matsuda N
    J Biol Chem; 2015 Oct; 290(42):25199-211. PubMed ID: 26260794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease.
    Beasley SA; Hristova VA; Shaw GS
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3095-100. PubMed ID: 17360614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.
    Aguirre JD; Dunkerley KM; Lam R; Rusal M; Shaw GS
    J Biol Chem; 2018 Apr; 293(17):6337-6348. PubMed ID: 29530980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.
    Imai Y; Soda M; Takahashi R
    J Biol Chem; 2000 Nov; 275(46):35661-4. PubMed ID: 10973942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation.
    Avraham E; Rott R; Liani E; Szargel R; Engelender S
    J Biol Chem; 2007 Apr; 282(17):12842-50. PubMed ID: 17327227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells.
    Koch A; Lehmann-Horn K; Dächsel JC; Gasser T; Kahle PJ; Lücking CB
    Parkinsonism Relat Disord; 2009 Mar; 15(3):220-5. PubMed ID: 18586549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination.
    Lim MK; Kawamura T; Ohsawa Y; Ohtsubo M; Asakawa S; Takayanagi A; Shimizu N
    Exp Cell Res; 2007 Aug; 313(13):2858-74. PubMed ID: 17512523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UbMES and UbFluor: Novel probes for ring-between-ring (RBR) E3 ubiquitin ligase PARKIN.
    Park S; Foote PK; Krist DT; Rice SE; Statsyuk AV
    J Biol Chem; 2017 Oct; 292(40):16539-16553. PubMed ID: 28710279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational Impact on "in-Between-Ring" (IBR) Domain of PARKIN on Protein Stability and Function.
    Biswas S; Bagchi A
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1603-1616. PubMed ID: 33471285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
    Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
    Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of phosphorylated UBL domain and insights into PINK1-orchestrated parkin activation.
    Aguirre JD; Dunkerley KM; Mercier P; Shaw GS
    Proc Natl Acad Sci U S A; 2017 Jan; 114(2):298-303. PubMed ID: 28007983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of parkin reveals mechanisms for ubiquitin ligase activation.
    Trempe JF; Sauvé V; Grenier K; Seirafi M; Tang MY; Ménade M; Al-Abdul-Wahid S; Krett J; Wong K; Kozlov G; Nagar B; Fon EA; Gehring K
    Science; 2013 Jun; 340(6139):1451-5. PubMed ID: 23661642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin-phosphoubiquitin complex reveals cryptic ubiquitin-binding site required for RBR ligase activity.
    Kumar A; Chaugule VK; Condos TEC; Barber KR; Johnson C; Toth R; Sundaramoorthy R; Knebel A; Shaw GS; Walden H
    Nat Struct Mol Biol; 2017 May; 24(5):475-483. PubMed ID: 28414322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the human Parkin ligase domain in an autoinhibited state.
    Wauer T; Komander D
    EMBO J; 2013 Jul; 32(15):2099-112. PubMed ID: 23727886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin.
    Caulfield TR; Fiesel FC; Moussaud-Lamodière EL; Dourado DF; Flores SC; Springer W
    PLoS Comput Biol; 2014 Nov; 10(11):e1003935. PubMed ID: 25375667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoregulation of Parkin activity through its ubiquitin-like domain.
    Chaugule VK; Burchell L; Barber KR; Sidhu A; Leslie SJ; Shaw GS; Walden H
    EMBO J; 2011 Jun; 30(14):2853-67. PubMed ID: 21694720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluor.
    Foote PK; Statsyuk AV
    Curr Protoc Chem Biol; 2018 Sep; 10(3):e45. PubMed ID: 30063295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.